Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: Role of GLP-1 and GLP-1 receptor

European Journal of Pharmacology

Volumn 720, Issue 1-3, 2013, Pages 158-165

  Abd El Motteleb, Dalia M ^a   Elshazly, Shimaa M ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

GLP 1 receptor; L NAME; MDA; Nephropathy; NO; Sitagliptin

Indexed keywords

CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MESSENGER RNA; N ACETYL BETA GLUCOSAMINIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SITAGLIPTIN; SUPEROXIDE DISMUTASE; UREA; XANTHINE OXIDASE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHRONIC DRUG ADMINISTRATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERTENSION; HYPERTENSIVE NEPHROPATHY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RENAL PROTECTION; TREATMENT DURATION; UPREGULATION; UREA BLOOD LEVEL; URINARY EXCRETION; URINE LEVEL;

GLP-1 RECEPTOR; L-NAME; MDA; NEPHROPATHY; NO; SITAGLIPTIN;

ANIMALS; BLOOD GLUCOSE; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; GLUCAGON-LIKE PEPTIDE 1; GLUTATHIONE PEROXIDASE; HYPERTENSION; HYPERTENSION, RENAL; HYPOGLYCEMIC AGENTS; KIDNEY; LIPID PEROXIDATION; MALE; NEPHRITIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PYRAZINES; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; SUPEROXIDE DISMUTASE; TRIAZOLES;

EID: 84890122260     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.033     Document Type: Article

References (53)

1. M. Araujo, and W.J. Welch Oxidative stress and nitric oxide in kidney function Curr. Opin. Nephrol. Hypertens 15 1 2006 72 77
2. L.L. Baggio, and D.J. Drucker Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review Treat. Endocrinol 1 2002 117 125 (Pubitemid 36828431)
3. J.D. Bancroft, and M. Gamble Theory and Practice of Histological Techniques fifth ed. 2002 Edinburgh Churchil, Livingstone, New York, London 165 180
4. C. Baylis, B. Mitruka, and A. Deng Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage J. Clin. Invest 90 1992 278 281
5. A.J. Bergman, C. Stevens, Y. Zhou, B. Yi, M. Laethem, M. De Smet, K. Snyder, D. Hilliard, W. Tanaka, W. Zeng, M. Tanen, A.Q. Wang, L. Chen, G. Winchell, M.J. Davies, S. Ramael, J.A. Wagner, and G.A. Herman Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers Clin. Ther 28 2006 55 72 (Pubitemid 43254990)
6. L.D. Bowers, and E.T. Wong Kinetic serum creatinine assays. II. A critical evaluation and review Clin. Chem 26 5 1980 555 561
7. L. Chaykovska, J. von Websky KRahnenführer, M Alter, S. Heiden, H Fuchs, F. Runge, T. Klein, and B. Hocher Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy PLoS One 6 11 2011 e27861
8. B. Chen, A. Moore, L.V. Escobedo, M.S. Koletsky, D. Hou, R.J. Koletsky, and P. Ernsberger Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats Exp. Biol. Med. 236 2011 309 314
9. C.F. Deacon, and J.J. Holst Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes.a historical perspective Biochem. Biophys. Res. Commun 294 2002 1 4 (Pubitemid 34687205)
10. V. De Gennaro Colonna, A. Rigamonti, S. Fioretti, S. Bonomo, B. Manfredi, P. Ferrario, M. Bianchi, F. Berti, E.E. Muller, and G. Rossoni Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats Eur. J. Pharmacol 516 3 2005 253 259 (Pubitemid 40922746)
11. A.M. Devlin, M.J. Brosnan, D. Graham, J.J. Morton, A.R. McPhaden, M. McIntyre, C.A. Hamilton, J.L. Reid, and A.F. Dominiczak Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo Am. J. Physiol 274 1 Pt 2 1998 H52 H59
12. S. Dhillon Sitagliptin: a review of its use in the management of type 2 diabetes mellitus Drugs 70 4 2010 489 512
13. M.E. Doyle, and J.M. Egan Mechanisms of action of GLP-1 in the pancreas Pharmacol. Ther. 113 3 2007 546 593
14. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrite and nitrate in biological fluids Anal. Biochem 126 1982 131 138 (Pubitemid 13203451)
15. C.A. Hamilton, G. Berg, M. Mcintyre, A.R. Mcphaden, J.L. Reid, and A.F. Dominiczak Effects of nitric oxide and superoxide on relaxation in human artery and vein Atherosclerosis 133 1997 77 86 (Pubitemid 27322120)
16. F. Helle, B.M. Iversen, and C. Chatziantoniou Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage Am. J. Physiol. Renal Physiol 298 5 2010 F1170 F1177
17. J.J. Holst The physiology of glucagon-like peptide 1 Physiol. Rev 87 2007 1409 1439 (Pubitemid 350041474)
18. P.L. Huang, Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, and M.C. Fishman Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 6546 1995 239 242
19. K. Husain Exercise conditioning attenuates the hypertensive effects of nitric oxide synthase inhibitor in rat Mol. Cell. Biochem 231 2002 129 137 (Pubitemid 34257231)
20. H.Y. Jin, W.J. Liu, J.H. Park, H.S. Baek, and T.S. Park Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats Arch. Med. Res 40 2009 536 544
21. K.W. Joo, S. Kim, S.Y. Ahn, H.J. Chin, D.W. Chae, J. Lee, J.S. Han, and K.Y. Na Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney BMC Kidney Nephrol 27 2013 14 98
22. P. Kakkar, B. Das, and P.N. Viswanathan A modified spectrophotometric assay of superoxide dismutase (SOD) Indian J. Biochem. Biophys 21 1984 130 132 (Pubitemid 15207169)
23. M.M. Khattab, A. Mostafa, and O. Al-Shabanah Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat Kidney Blood Pressure Res 28 2005 243 250 (Pubitemid 43048614)
24. R. Kodera, K. Shikata, H.U. Kataoka, T. Takatsuka, S. Miyamoto, M. Sasaki, N. Kajitani, S. Nishishita, K. Sarai, D. Hirota, C. Sato, D. Ogawa, and H. Makino Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes Diabetologia 54 2011 965 978
25. L Kopkan, and D.S. Majid Enhanced superoxide activity modulates renal function in no-deficient hypertensive rats Hypertension 47 2006 568 572 (Pubitemid 43843877)
26. L. Liu, J. Liu, T.W. Wong, X.Y. Tian, C.W. Lau, Y. Wang, G. Xu, Y. Pu, Z. Zhu, A. Xu, K.S. Lam, Z.Y. Chen, C.F. Ng, X. Yao, and Y. Huang Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism Hypertension 60 2012 833 841
27. W.J. Liu, S.H. Xie, Y.N. Liu, W. Kim, H.Y. Jin, S.K. Park, Y.M. Shao, and T.S. Park Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats J. Pharmacol. Exp. Ther 340 2012 248 255
28. K. Livak, and T. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT Methods 25 2001 402 408 (Pubitemid 34164012)
29. T.F. Lüscher, and L. Raij Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats Hypertension 9 2 1987 157 163 (Pubitemid 17027829)
30. C. Mega, E.T. de Lemos, H. Vala, R. Fernandes, J. Oliveira, F. Mascarenhas-Melo, F. Teixeira, and F. Reis Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat) Exp. Diabetes Res 2011 10.1155/2011/162092
31. P.F. Mount, and D.A. Power Nitric oxide in the kidney: functions and regulation of synthesis Acta Physiol. 187 4 2006 433 446
32. M. Nakayama, T. Sato, M. Miyazaki, M. Matsushima, H. Sato, Y. Taguma, and S. Ito Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study Hypertens. Res 34 10 2011 1106 1110
33. F. Ö ktem, F. Ozguner, H.R. Yilmaz, E. Uz, and B. Dündar Melatonin reduces urinary excretions of N-acetyl-b-d-glucosaminidase, albumin and renal oxidative markers in diabetic rats Clin. Exp. Pharmacol. Physiol 33 2006 95 101
34. F. Ö ktem, A. Kirbas, A. Armagan, A.E. Kuybulu, R.H. Yilmaz, F. Ö zguner, and Uz. Efkan Lisinopril attenuates renal oxidative injury in L-NAME-induced hypertensive rats Mol. Cell. Biochem 352 2011 247 253
35. I.M. Ott, M.L. Alter, K. von Websky, A. Kretschmer, O. Tsuprykov, Y. Sharkovska, K. Krause-Relle, J. Raila, A. Henze, J.P. Stasch, and B. Hocher Effect of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade PLoS One 7 8 2012 e42623
36. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J. Lab. Clin. Med 70 1976 158 169
37. C.W. Park, H.W. Kim, S.H. Ko, J.H. Lim, G.R. Ryu, H.W. Chung, S.W. Han, S.J. Shin, B.K. Bang, M.D. Breyer, and Y.S. Chang Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice J. Am. Soc. Nephrol 18 2007 1227 1238 (Pubitemid 46536909)
38. M.O. Ribeiro, E. Antunes, G. de Nucci, S.M. Lovisolo, and R. Zatz Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension Hypertension 20 3 1992 298 303
39. G. Rogers, and T. Oosthuyse A comparison of the indirect estimate of mean arterial pressure calculated by the conventional equation and calculated to compensate for a change in heart rate Int. J. Sports Med 21 2 2000 90 95 (Pubitemid 30128551)
40. K. Satoh Serum lipid peroxide in cerebrovascular disorders determined by a new calorimetric method Clin. Chim. Acta 90 1 1978 37 43 (Pubitemid 9055456)
41. P. Schlatter, C. Beglinger, J. Drewe, and H. Gutmann Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells Regul. Pept 141 2007 120 128 (Pubitemid 46482693)
42. C.G. Schnackenberg, W.J. Welch, and C.S. Wilcox Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide Hypertension 32 1 1998 59 64 (Pubitemid 28324125)
43. M.D. Shephard, and R.D. Mezzachi Scientific and technical committee, Technical report no. 8. The collection, preservation, storage and stability of urine specimens for routine clinical biochemical analysis Clin. Biochem. Rev 4 1983 61 67
44. D.A. Sorg, and B. Buckner A simple method of obtaining venous blood from small laboratory animals Proc. Soc. Exp. Biol. Med 115 1964 1131 1132
45. N.R. Sundaresan, M. Gupta, G. Kim, S.B. Rajamohan, A. Isbatan, and M.P. Gupta Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice J. Clin. Invest 119 9 2009 2758 2771
46. R.M. Touyz, and E.L. Schiffrin Reactive oxygen species in vascular biology: implications in hypertension Histochem. Cell. Biol 122 2004 339 352 (Pubitemid 39506592)
47. P. Trinder Determination of glucose in blood using oxidase with alternative oxygen receptor Ann. Clin. Biochem 6 1969 24 27
48. S. Ulker, P.P. McKeown, and U. Bayraktutan Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD (P) H oxidase activities Hypertension 41 3 2003 534 539 (Pubitemid 36314628)
49. J. Vaghasiya, N. Sheth, Y. Bhalodia, and R. Manek Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes Regul. Pept. 166 2011 48 54
50. D. Webster, A.H. Bignell, and E.C. Attwood An assessment of the suitability of bromocresol green for the determination of serum albumin Clin. Chim. Acta 53 1 1974 101 108
51. M. Yakata, O. Sugita, T. Sakai, K. Uchiyama, and K. Wada Urinary enzyme determination and its clinical significance. Enzyme derived from the kidney epithelium-N acetyl beta-Dglucosaminidase.4. Preclinical evaluation of the urinary NAG activity and changes in the renal disease Rinsho Byori 56 1983 90 101
52. C. Zhang, S.Z. Imam, S.F. Ali, and P.R. Mayeux Peroxynitrite and the regulation of Na (+), K(+)-ATPase activity by angiotensin II in the rat proximal tubule Nitric Oxide 7 2002 30 35 (Pubitemid 35007257)
53. Y. Zhang, R. Jang, T.A. Mori, K.D. Croft, C.G. Schyvens, K.U. McKenzie, and J.A. Whitworth The anti-oxidant tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat J. Hypertens 21 2003 1513 1518 (Pubitemid 36994130)